Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIVATE in VWD patients undergoing surgery
NCT00404300Phase 3Terminated
- Sponsor
- Bio Products Laboratory
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of factor viii + von Willebrand factor in von Willebrand disease (VWD), sponsored by Bio Products Laboratory. Started Feb 2007; status: terminated.
02
Drugs
factor viii + von Willebrand factor
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NCT00404300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404300.